Series A

With a fresh $14M in Series A funding, Rebar's AI platform is automating age-old processes for HVAC, electrical, and plumbing contractors.

With its new oversubscribed fund, Scout Ventures is doubling down on veteran-led startups building the next generation of national security technology.

The private equity firm hires Laura Noisten to lead leveraged finance, a strategic move to fuel growth in the complex aerospace and defense tech sector.

Finance veteran Stephen Siderow brings institutional expertise to a burgeoning real estate tech VC, aiming to capitalize on AI-driven disruption.

BriefCatch launches RealityCheck, a new tool to combat AI-generated legal errors as courts increasingly sanction lawyers for submitting fabricated citations.

Middle and high schoolers are building AI to aid surgery and streamline recycling, signaling a major shift from college prep to real-world innovation.

A North Carolina startup claims a massive efficiency leap in Direct Air Capture, putting the sub-$100/ton 'holy grail' of carbon removal within reach.

As AI reshapes medicine, one veterinary firm's 'No AI' policy is earning major awards and the loyalty of the vets it serves. Here's why.

Dr. Pietro Garbelli's award-winning book offers a crucial roadmap for responsibly integrating AI, balancing high-tech innovation with patient trust.

A new drug for Raynaud's phenomenon in scleroderma patients significantly boosts attack-free days, offering hope despite missing its primary trial goal.

Fueled by strong investor demand and a lead order from Purpose Global Resource Fund, Lithium Africa will acquire a key South African lithium asset.

With book value soaring, Stack Capital offers a rare public window into the massive valuations of private titans like SpaceX and the AI infrastructure boom.

With FDA Breakthrough status for its MASH drug, a new CEO, and a fortified balance sheet, Altimmune is poised to take on serious liver disease and addiction.

A new strategic partnership between AlbaCore and MUFG aims to unlock billions for UK and European infrastructure, offering investors access to stable returns.

Phoenix innovator GACW proves its steel Air Suspension Wheel in brutal -40°F mining tests, paving the way for a safer, non-pneumatic 2026 commercial release.

HYCU earns its sixth straight CRN 5-Star award, signaling market dominance through its partner-first strategy and expansive R-Cloud SaaS support.

SaaS growth expert Eric Shoemaker takes the helm at Keebo, aiming to scale its AI-powered platform amid soaring enterprise demand for cloud cost control.

Argo Biopharma's new CFO/CSO, Dr. Gena Wang, leaves a star analyst career at Barclays, signaling a major validation for the company's siRNA platform.

Novos Power and WearableDose win FedTech's Crucible competition, highlighting critical innovations in power grid stability and real-time radiation monitoring.

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?